Desoxyepothilone B: all 33 studies that test it
Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast CancerNot yet recruitingNCT07684456Phase 3
- A Phase II Study of Utidelone With Toripalimab in Advanced Cervical CancerNot yet recruitingNCT07363330Phase 2
- Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingNCT07044349Phase 2
- Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC PatientsNot yet recruitingNCT07021261Phase 3
- Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT06973421Phase 2
- Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT06841679Phase 2/3
- A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesRecruitingNCT06764940Phase 2
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingNCT06730581Phase 2
- Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingNCT06683703Phase 2
- A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBCRecruitingNCT06598046Phase 2
- The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical StudyRecruitingNCT06125080Phase 2
- Utidelone Treated for the Recurrent or Metastatic Urothelial CarcinomaRecruitingNCT05895864Phase 2
- Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal CancerRecruitingNCT05866510Phase 2
- Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT05673590Phase 3
- Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast CancerRecruitingNCT05430399Phase 3
- Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast CancerRecruitingNCT05398861Phase 2
- A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid TumorsWithdrawnNCT07449481Phase 2
- Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast CancerActive, not recruitingNCT06458413Phase 2
- Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid TumorsActive, not recruitingNCT05700084Phase 1/2
- Tolerability of Utidelone Capsule in Patients With Advanced Solid TumorsStatus unknownNCT05681000Phase 1
- Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast CancerStatus unknownNCT05403333Phase 2
- Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain MetastasesStatus unknownNCT05357417Phase 2
- Utidelone in Third-line and Above Treatment of Small Cell Lung CancerStatus unknownNCT05299255Phase 2
- PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerCompletedNCT05052437Phase 1
- Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04911907Phase 2
- Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal CancerSuspendedNCT03906565Phase 2
- Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）CompletedNCT03693547Phase 2
- A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT00337649Phase 1/2
- Study of KOS-862 (Epothilone D) in Metastatic Prostate CancerTerminatedNCT00104130Phase 2
- Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyCompletedNCT00081107Phase 2
- Effectiveness of KOS-862 in the Treatment of Lung CancerTerminatedNCT00080509Phase 2
- Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal CancerCompletedNCT00077259Phase 2
- A Trial to Evaluate Epothilone D in Patients With Advanced Solid TumorsCompletedNCT00030173Phase 1